HomeNewsTrendsCurrent AffairsCOVID-19 vaccination based on vulnerability of citizens to infection, not profession wise: Centre told Delhi HC

COVID-19 vaccination based on vulnerability of citizens to infection, not profession wise: Centre told Delhi HC

The Centre made the submission in response to a PIL initiated by the high court to examine the demand to declare all people associated with the judicial functioning, including judges, court staff and lawyers, as “frontline workers” so that they could receive COVID-19 vaccination on priority and without limitations of their age or physical condition.

March 10, 2021 / 18:20 IST
Story continues below Advertisement
Representative image: Reuters
Representative image: Reuters

The Centre on Wednesday told the Delhi High Court that the decision for COVID-19 vaccination is based on vulnerability of citizens to the disease and is not profession wise and the government is sensitive to the needs of the country.

The Centre made the submission in response to a PIL initiated by the high court to examine the demand to declare all people associated with the judicial functioning, including judges, court staff and lawyers, as “frontline workers” so that they could receive COVID-19 vaccination on priority and without limitations of their age or physical condition.

Story continues below Advertisement

A bench of Justices Vipin Sanghi and Rekha Palli said it hopes that the government is sensitive to the needs of citizens and the country and due to the pandemic courts functioning has also taken a huge hit.

“Judiciary is an important wing and one of the three pillars of the state. To compare it with others is not correct. Its functioning is getting hampered. Nobody can deny that efficiency of cases has taken a huge hit. Hundreds and thousands of people congregate here daily and everyday different people are coming. Risk of exposure is there,” the bench said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show